An upward revision of the nation's third quarter gross domestic product lifted the markets to a higher open with the Dow gaining 64 points to 16,243. Nasdaq climbed 17 points to 4076.
On the upside
The Food and Drug Administration delayed its decision on Amarin's (Nasdaq: AMRN) supplemental new drug application as it continues to consider reinstating the ANCHOR Special Protocol Assessment agreement for Vascepa.
Sycamore Partners will take Jones Group (NYSE: JNY) private for approximately $1.2 billion.
Red Hat (NYSE: RHT) impressed with sharply higher third quarter earnings and revenue that surpassed analyst expectations.
On the downside
Tibco Software (Nasdaq: TIBX) reported flat fourth quarter earnings and forecast current quarter results below estimates.
Fastenal (Nasdaq: FAST) warned that fourth quarter earnings would fall short of expectations.
Third quarter earnings rose for CarMax (NYSE: KMX) but the results missed estimates.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 rose 6 points to 1816. Bitcoin soared $31.21 or 4.37% to $745.00.
